SPL RF Sep 2022

EN_01537156_0472

30,00 EUR Private use
Making print for private purpose, storage in computer memory, no distribution rights.
40,00 EUR Internet - private use
Strictly for editorial, single use on a personal (nonprofit) web site, Internet portal, social media (Facebook, Instagram etc.), blog for 1 year. Not for resale. Maximum picture size 2000px.
75,00 EUR Internet commercial use
Strictly for editorial, single use on a commercial web site, Internet portal, social media (Facebook, Instagram etc.), blog for 1 year. Not for resale. Maximum picture size 2000px.
90,00 EUR Print use
Strictly for editorial, single use, inside of newspaper, magazine, book (including digital version), one edition, one single country. Not for resale.

Gross prices

special instructions

Internet +100% SPECIAL RATES FOR EDITORIAL AND BOOKS RF RATES FOR OTHER USE

caption

Illustration of an engineered receptor (light blue) on the surface of a natural killer cell binds specifically to PD-L1 molecules (red) on a cancer cell. This activates a signal cascade in the NK cell leading to the segregation of vesicles that contain perforin and granzyme. The perforins build channels for the granzymes which enter the leukemia cell and activate finally the apoptosis (cell death) of the cancer cell.

headline SPL RF Sep 2022

created date 2022-09-03

credit JUAN GAERTNER/Science Photo Library RF/East News

source Science Photo Library RF

byline JUAN GAERTNER

original transmission reference f0365765

weight 7,13MB

size 68cm x 51cm by 300dpi

keywords - Show

ANTIBODY, ANTIGEN, ARTIFICIAL, ARTWORK, BIOCHEMICAL, BIOCHEMISTRY, BIOENGINEERING, BIOLOGICAL, BIOLOGY, BIOMOLECULE, BIOTECHNOLOGY, CANCER, CAR, CELL, CHIMERIC, DEATH, ENZYME, GAERTNER, IMMUNE, IMMUNORECEPTOR, IMMUNOTHERAPY, JUAN, KILLER, MEMBRANE, MOLECULAR, NATURAL, NK, NO-ONE, NOBODY, PD-L1, PROTEIN, RECEPTOR, SIGNAL, SPECIFIC, SYSTEM, THERAPY, TUMOR,